Fibrous Dysplasia synonyms

Fibrous dysplasia is a rare skeletal disorder where normal bone and marrow are replaced by fibrous tissue, and it is most commonly referred to by this name in modern medical literature. While historical terms like Lichtenstein-Jaffe disease or McCune-Albright syndrome (in specific systemic cases) exist, fibrous dysplasia remains the standard clinical nomenclature used across global health systems.

Why are there multiple names for Fibrous Dysplasia?

The nomenclature for fibrous dysplasia has evolved as medical researchers gained a deeper understanding of its pathophysiology. Historically, the condition was described by various authors who identified specific skeletal patterns, leading to eponyms that are now largely considered archaic. The shift toward the term fibrous dysplasia reflects a move toward descriptive, evidence-based naming that avoids confusion between localized skeletal lesions and the more complex, systemic manifestations often associated with the condition.

What are the historical and alternative names for this condition?

In older medical records or international literature, you may encounter several synonyms or related terms. It is important to distinguish between the isolated form of the disease and instances where it occurs with other endocrine or skin abnormalities. Historically recognized terms and associated names include:

• Lichtenstein-Jaffe disease (an older eponym referencing the researchers who first formally classified the pathology).


• Albright’s syndrome (often used historically, though now specifically associated with the McCune-Albright variant).


• Polyostotic fibrous dysplasia (used when multiple bones are involved).


• Monostotic fibrous dysplasia (used when the condition is limited to a single bone).

How is Fibrous Dysplasia classified in major medical systems?

Standardized medical classification systems use specific codes to track fibrous dysplasia to ensure consistency in research and insurance billing. These systems provide a universal language for clinicians regardless of geographic location:

1. Orphanet: Listed under ORPHA:337, categorized as a rare bone disease.


2. OMIM (Online Mendelian Inheritance in Man): Referenced under ID #174800.


3. ICD-10-CM: Classified under code M85.0 (Fibrous dysplasia of bone).

Which name is currently preferred by medical professionals?

Today, the term fibrous dysplasia is the gold standard for diagnosis and clinical communication. When the condition involves multiple bones and is accompanied by café-au-lait skin pigmentation and endocrine hyperfunction, clinicians specifically use the term McCune-Albright syndrome. Using the precise term fibrous dysplasia helps patients coordinate care across specialties, including orthopedics, endocrinology, and genetics, ensuring that medical records are accurate and searchable across global databases like those found at DiseaseMaps.org, where 280 community members currently share their experiences.

Next steps

• Consult with an orthopedic oncologist or a metabolic bone disease specialist to confirm your diagnosis and treatment plan.


• Request your medical records to ensure the correct ICD-10 code (M85.0) is utilized for accurate documentation.


• Connect with the 280+ members of the DiseaseMaps.org community to share resources and experiences regarding your diagnosis.


• Verify if your specific case is isolated or part of a broader syndrome like McCune-Albright by consulting with a clinical geneticist.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: https://www.orpha.net (Search: Fibrous dysplasia)


• NIH Genetic and Rare Diseases (GARD) Information Center: https://rarediseases.info.nih.gov


• OMIM (Online Mendelian Inheritance in Man): https://omim.org


• Fibrous Dysplasia Foundation: https://fibrousdysplasia.org